The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. By working with scientists, doctors and researchers, the company strives to develop better assessment and treatment modalities for the industry and focuses on developing programs and techniques for North America.
Cyborg Score Rationale
Stock trades at extreme penny-stock levels ($0.0001 as of June 25, 2026) with minimal market capitalization (~$772K) and very low volume. Company is not current in SEC reporting obligations, indicating severe financial and operational distress despite operating treatment facilities across multiple states.
Top Insights
OTC-traded micro-cap with penny-stock valuation and minimal trading volume, indicating severe shareholder value erosion
Operates 447 total treatment beds across four facilities: 87 beds in Florida (West Palm Beach/Boca Raton) and 360 beds in Kentucky (Morehead/Paducah)
Company is not current in SEC reporting obligations as of June 2026, creating regulatory risk and reducing data transparency
Stock is restricted to unsolicited quotes only with wider spreads and higher volatility, making liquidation difficult for investors
Named Competitors
Ascension Behavioral Health — Large integrated behavioral health and addiction treatment network
Hazelden Betty Ford — Nonprofit addiction treatment and recovery services
Magellan Health — Behavioral health and substance use disorder treatment services
Recent Developments
(January 2025) Related party Eileen Maria Greene acquired 44,092,551 shares
(November 2024) Company reporting activity detected
(August 2024) Public announcement regarding company operations
Open the full interactive Ethema Health Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.